Skip to main content
Top

20-02-2018 | Rheumatoid arthritis | Review | Article

Physical articular examination in the activity of rheumatoid arthritis: a systematic review of the literature

Journal: Clinical Rheumatology

Authors: Yimy F. Medina, Rafael Eduardo Ruíz-Gaviria, Adriana Buitrago-Lopez, Catalina Villota

Publisher: Springer London

Abstract

To summarize evidence concerning the articular examination needed to determine rheumatoid arthritis (RA) activity (follow-up or control) via a systematic review. A search of Medline, Embase, Lilacs, SciELO, the Web of Science, the National Technical Reports Library, and the reference lists of relevant studies through March 2017 was conducted using a systematic methodology to identify studies of patients with RA older than 18 years in which a detailed description of the physical examination or a description of the components of the articular examination was provided. Of 8322 references, 74 studies were included according to the selection criteria, and 6 references were ultimately included at the end of the review. Most of the included studies (n = 5) were associated with a moderate risk of bias. There was great variability among the studies and the articular examination methods used. Some studies presented the examination with a complete specification of the technique (n = 2), the consensus of rheumatologists (n = 2), or training through audiovisual materials and face-to-face courses (n = 2), but none of the studies explicitly showed the technique by which the physical examination was performed. Despite the importance of the clinical evaluation and physical examination of patients with RA for diagnosis, prognosis, clinimetrics, and follow-up, evidence concerning how to perform the articular examination is scarce.
Literature
1.
Gibofsky A (2012) Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 18(13 Suppl):S295–S302PubMed
2.
Gabriel SE (2001) The epidemiology of rheumatoid arthritis. Rheum Dis Clin N Am 27(2):269–281. https://​doi.​org/​10.​1016/​S0889-857X(05)70201-5 CrossRef
3.
Bautista-Molano W, Fernández-Avila D, Jiménez R, Cardozo R, Marín A, Soler MDP, Gómez O, Ruiz O (2016) Epidemiological profile of colombian patients with rheumatoid arthritis in a specialized care clinic. Reumatol Clin 12(6):313–318. https://​doi.​org/​10.​1016/​j.​reuma.​2015.​11.​009 CrossRefPubMed
4.
Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, Gabriel SE, Matteson EL, Bongartz T (2013) Incidence and mortality of obstructive lung disease in rheumatoid arthritis: a population-based study. Arthritis Care & Research 65(8):1243–1250. https://​doi.​org/​10.​1002/​acr.​21986 CrossRef
5.
Amaya-Amaya J, Montoya-Sánchez L, Rojas-Villarraga A (2014) Cardiovascular involvement in autoimmune diseases. Biomed Res Int 2014:1–31. https://​doi.​org/​10.​1155/​2014/​367359 CrossRef
6.
Samanci N, Ozdem S, Akbas H, Mutlu D, Gultekin M, Arman M et al (2005) Diagnostic value and clinical significance of anti-CCP in patients with advanced rheumatoid arthritis. J Natl Med Assoc 97:1120–1126PubMedPubMedCentral
7.
Medina YF, Ortiz M, Barrera N, Chalem P, Motta A, Zamora F et al (2011) Relación de los anticuerpos anti-péptido citrulinado con manifestaciones osteo-articulares en una cohorte de pacientes con esclerodermia. Rev Colomb Reumatol 18:155–162
8.
Nam JL, Ramiro S, Gaujoux-Viala C, Takase K, Leon-Garcia M, Emery P, Gossec L, Landewe R, Smolen JS, Buch MH (2014) Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 73(3):516–528. https://​doi.​org/​10.​1136/​annrheumdis-2013-204577 CrossRefPubMed
9.
Lam S (2016) JAK inhibitors: a broadening approach in rheumatoid arthritis. Drugs Today Barc Spain: 1998 52:467–469. https://​doi.​org/​10.​1358/​dot.​2016.​52.​8.​2543995 CrossRef
10.
Cárdenas M, de la Fuente S, Castro-Villegas MC, Romero-Gómez M, Ruiz-Vílchez D, Calvo-Gutiérrez J, Escudero-Contreras A, del Prado JR, Collantes-Estévez E, Font P (2016) Cost-effectiveness of clinical remission by treat to target strategy in established rheumatoid arthritis: results of the CREATE registry. Rheumatol Int 36(12):1627–1632. https://​doi.​org/​10.​1007/​s00296-016-3583-3 CrossRefPubMed
11.
Dwyer KA, Coty MB, Smith CA, Dulemba S, Wallston KA (2001) A comparison of two methods of assessing disease activity in the joints. Nurs Res 50(4):214–221. https://​doi.​org/​10.​1097/​00006199-200107000-00005 CrossRefPubMed
12.
Salaffi F, Cimmino MA, Leardini G, Gasparini S, Grassi W, Epidemiology Study Grp Italian, S (2009) Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the disease activity score including 28 joints (DAS28) compared with the clinical disease activity index (CDAI). Clin Exp Rheumatol 27:552–559PubMed
13.
Vega-Morales D, Esquivel-Valerio JA, Garza-Elizondo MA (2015) Do rheumatologists know how to squeeze? Evaluations of Gaenslen’s maneuver. Rheumatol Int 35(12):2037–2040. https://​doi.​org/​10.​1007/​s00296-015-3354-6 CrossRefPubMed
14.
Levy G, Cheetham C, Cheatwood A, Burchette R (2007) Validation of patient-reported joint counts in rheumatoid arthritis and the role of training. J Rheumatol 34(6):1261–1265PubMed
15.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical Research Ed) 339:b2535CrossRef
16.
Funovits J, Aletaha D, Bykerk V, Combe B, Dougados M, Emery P, Felson D, Hawker G, Hazes JM, Huizinga T, Kay J, Kvien TK, Smolen JS, Symmons D, Tak PP, Silman A (2010) The 2010 American College of Rheumatology/European league against rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Ann Rheum Dis 69(9):1589–1595. https://​doi.​org/​10.​1136/​ard.​2010.​130310 CrossRefPubMed
17.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clinical Res Ed) 355:i4919
18.
van Riel PLCM, van Gestel AM, Scott DL, European League against Rheumatism and Standing Committee for International Clinical Studies including Therapeutic Trials (2000) EULAR handbook of clinical assessments in rheumatoid arthritis: on behalf of the EULAR Standing Committee for International Clinical Studies Including Therapeutic Trials -ESCISIT (chairman, Piet L.C.M van Riel). Van Zuiden, The Netherlands
19.
Higgins JPT, Green S, Cochrane Collaboration, editors (2008) Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell, ChichesterCrossRef
20.
Cheung PP, Dougados M, Andre V, Balandraud N, Chalès G, Chary-Valckenaere I, Dernis E, Gill G, Gilson M, Guis S, Mouterde G, Pavy S, Pouyol F, Marhadour T, Richette P, Ruyssen-Witrand A, Soubrier M, Nguyen M, Gossec L (2014) The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritis. Joint Bone Spine 81(2):154–159. https://​doi.​org/​10.​1016/​j.​jbspin.​2013.​06.​006 CrossRefPubMed
21.
Grunke M, Antoni CE, Kavanaugh A, Hildebrand V, Dechant C, Schett G et al (2010) Standardization of joint examination technique leads to a significant decrease in variability among different examiners. J Rheumatol 37(4):860–864. https://​doi.​org/​10.​3899/​jrheum.​090195 CrossRefPubMed
22.
Kane D, Balint PV, Sturrock RD (2003) Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis. J Rheumatol 30(5):966–971PubMed
23.
Kim HA, Kim SH, Seo YI (2007) Ultrasonographic findings of the shoulder in patients with rheumatoid arthritis and comparison with physical examination. J Korean Med Sci 22(4):660–666. https://​doi.​org/​10.​3346/​jkms.​2007.​22.​4.​660 CrossRefPubMedPubMedCentral
24.
Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A (2005) Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis 64(3):375–381. https://​doi.​org/​10.​1136/​ard.​2004.​023929 CrossRefPubMedPubMedCentral
25.
Stone MA, White LM, Gladman DD, Inman RD, Chaya S, Lax M et al (2009) Significance of clinical evaluation of the metacarpophalangeal joint in relation to synovial/bone pathology in rheumatoid and psoriatic arthritis detected by magnetic resonance imaging. J Rheumatol 36(12):2751–2757. https://​doi.​org/​10.​3899/​jrheum.​080205 CrossRefPubMed
26.
Grassi W, De Angelis R, Lamanna G, Cervini C (1998) The clinical features of rheumatoid arthritis. Eur J Radiol 27(Suppl 1):S18–S24. https://​doi.​org/​10.​1016/​S0720-048X(98)00038-2 CrossRefPubMed
27.
Assistance Publique – Hôpitaux de Paris (Fr) (2015) LE RHUMATISMES en 100 questions [Internet]. Paris, France
28.
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324. https://​doi.​org/​10.​1002/​art.​1780310302 CrossRefPubMed
29.
Muirden KD (1998) Education in rheumatology. Ann Acad Med Singap 27:24–28PubMed
30.
Akesson K, Dreinhöfer KE, Woolf AD (2003) Improved education in musculoskeletal conditions is necessary for all doctors. Bull World Health Organ 81(9):677–683PubMedPubMedCentral
31.
Olson DP, Roth KE (2007) Diagnostic tools and the hands-on physical examination. Virtual Mentor 9(2):113–118. https://​doi.​org/​10.​1001/​virtualmentor.​2007.​9.​2.​jdsc1-0702 CrossRefPubMed
32.
Castrejon I, McCollum L, Tanriover MD, Pincus T (2012) Importance of patient history and physical examination in rheumatoid arthritis compared to other chronic diseases: results of a physician survey. Arthritis Care Res 64(8):1250–1255. https://​doi.​org/​10.​1002/​acr.​21650
33.
Walsh CAE, Mullan RH, Minnock PB, Slattery C, FitzGerald O, Bresnihan B (2008) Consistency in assessing the disease activity Score-28 in routine clinical practice. Ann Rheum Dis 67(1):135–136. https://​doi.​org/​10.​1136/​ard.​2007.​076885 CrossRefPubMed
34.
Cheung PP, Dougados M, Andre V, Balandraud N, Chales G, Chary-Valckenaere I, Chatelus E, Dernis E, Gill G, Gilson M, Guis S, Mouterde G, Pavy S, Pouyol F, Marhadour T, Richette P, Ruyssen-Witrand A, Soubrier M, Gossec L (2013) Improving agreement in assessment of synovitis in rheumatoid arthritis. Joint, Bone, Spine. Rev Rhum 80(2):155–159. https://​doi.​org/​10.​1016/​j.​jbspin.​2012.​07.​014
35.
Tugwell P, Boers M (1993) Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT committee. J Rheumatol 20(3):555–556PubMed